These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22670488)

  • 1. Biomarker panel for colon cancer rivals fecal occult blood test.
    Morrow T
    Manag Care; 2012 May; 21(5):51-2. PubMed ID: 22670488
    [No Abstract]   [Full Text] [Related]  

  • 2. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
    Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNA test as colon cancer screening. Hemoccult and colonoscopy are actually more reliable].
    Freitag MH
    MMW Fortschr Med; 2005 Apr; 147(16):10. PubMed ID: 16392392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood in feces. A screening method for early discovery of colorectal cancer].
    Kewenter J
    Lakartidningen; 1994 Mar; 91(9):803-4. PubMed ID: 8139343
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Inquiries. How does colonoscopy compare with fecal occult blood testing as a screening tool for colon cancer?
    Boggs BD; Stephens MM; Wallace R
    J Fam Pract; 2005 Nov; 54(11):996-7. PubMed ID: 16266608
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for colorectal cancer: the rationale and a recent advance in the detection of fecal occult blood.
    Friend WG
    Prog Clin Biol Res; 1985; 186():65-76. PubMed ID: 4034607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colonic and rectal cancer screening using fecal occult blood analysis (our experience)].
    Trignano M; Uzzau A; Nonnis R; Terrosu G; Noce L; Farris A
    Chir Ital; 1986 Oct; 38(5):511-8. PubMed ID: 3815641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The crypto-hem test in screening for colon cancer].
    Prokorov VV; Shabarov VL
    Vopr Onkol; 1988; 34(3):335-8. PubMed ID: 3358298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.
    Winawer SJ; Fleisher M
    Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917
    [No Abstract]   [Full Text] [Related]  

  • 12. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
    Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of diverticulosis coli and vascular ectasias and the results of fecal occult blood test.
    Nakama H; Fattah AS; Zhang B; Kamijo N; Uehara Y
    Hepatogastroenterology; 2000; 47(35):1277-9. PubMed ID: 11100332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early detection of colon carcinomas. Diagnostic series: fecal occult blood].
    Janssen K
    MMW Fortschr Med; 2000 Nov; 142(46):46. PubMed ID: 11132313
    [No Abstract]   [Full Text] [Related]  

  • 17. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.
    Yokoyama S; Shatney CH; Mochizuki H; Hase K; Johnson DL; Cummings S; Trollope ML; Tamakuma S
    Am Surg; 1997 Mar; 63(3):243-6; discussion 246-7. PubMed ID: 9036892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoccult screening for colon cancer by Hawaii's physicians.
    Withers JN; Wienke JW
    Hawaii Med J; 1981 Mar; 40(3):75-7. PubMed ID: 7239898
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood.
    Shields HM; Weiner MS; Henry DR; Lloyd JA; Ransil BJ; Lamphier DA; Gallagher DW; Antonioli DA; Rosner BA
    Am J Gastroenterol; 2001 Jan; 96(1):196-203. PubMed ID: 11197252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.